======= THAP1 ======= == Gene Information == * **Official Symbol**: THAP1 * **Official Name**: THAP domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55145|55145]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NVV9|Q9NVV9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=THAP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20THAP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609520|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene contains a THAP domain, a conserved DNA-binding domain. This protein colocalizes with the apoptosis response protein PAWR/PAR-4 in promyelocytic leukemia (PML) nuclear bodies, and functions as a proapoptotic factor that links PAWR to PML nuclear bodies. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: DNA-binding transcription regulator that regulates endothelial cell proliferation and G1/S cell-cycle progression. Specifically binds the 5'-[AT]NTNN[GT]GGCA[AGT]-3' core DNA sequence and acts by modulating expression of pRB-E2F cell-cycle target genes, including RRM1. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. May also have pro-apoptopic activity by potentiating both serum-withdrawal and TNF-induced apoptosis. {ECO:0000269|PubMed:12717420, ECO:0000269|PubMed:17003378, ECO:0000269|PubMed:20200153}. |THAP| |endothelial cell proliferation| |epithelial cell proliferation| |PML body| |fibrillar center| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |sequence-specific DNA binding| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cell population proliferation| |regulation of mitotic cell cycle| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |intracellular membrane-bounded organelle| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |protein homodimerization activity| |identical protein binding| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp70|INK128 0.2μM R02 exp70]]|-2.74| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|-2.52| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.36| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.27| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.25| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.99| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-1.89| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|-1.81| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.81| |[[:results:exp183|IU1-C 25μM R04 exp183]]|-1.8| |[[:results:exp274|Citral 50μM R06 exp274]]|-1.78| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-1.76| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-1.71| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.7| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|1.8| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.99| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.11| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|3.45| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 653/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|25/28| |blood|17/28| |bone|26/26| |breast|27/33| |central nervous system|50/56| |cervix|4/4| |colorectal|17/17| |esophagus|11/13| |fibroblast|1/1| |gastric|14/16| |kidney|18/21| |liver|19/20| |lung|68/75| |lymphocyte|10/16| |ovary|23/26| |pancreas|22/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|23/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|20/22| |urinary tract|24/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4810 * **Expression level (log2 read counts)**: 3.21 {{:chemogenomics:nalm6 dist.png?nolink |}}